Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News

November 8, 2019 — The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with ...

Home November 08, 2019
Home
News | Stents Bioresorbable

November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...

Home November 07, 2019
Home
The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) were evaluated to determine if there is an increased mortality risk due to paclitaxel, but was no difference was seen in the five-year mortality rates compared to control patients. #VIVA19 #VIVA #VIVA2019
Feature | Stents Peripheral | Dave Fornell, Editor

November 6, 2019 – The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) ...

Home November 06, 2019
Home
News | Peripheral Artery Disease (PAD)

November 6, 2019 – Boston Scientific announced positive data for two of its devices within the peripheral drug-eluting ...

Home November 06, 2019
Home
Viva conference late breaking clinical trials, #VIVA19 #VIVA #VIVA2019
Feature | VIVA

November 14, 2019 — The results of the 21 late-breaking clinical trials presented for the first time at Vascular ...

Home November 14, 2019
Home
EchoPixel showed technology at TCT 2019 that creates live holograms in the cath lab from 3-D TEE imaging. It projects the holograms on a special display screen that does not require the user to wear 3-D glasses. The interventional cardiologist can use hand movements and a foot switch to move the image around without breaking the sterile field. It offers a new way to visualize catheters, device positioning and deployment for structural heart procedures. #TCT2019 #TCT #TCT19
Feature | TCT | Dave Fornell, Editor

The latest in interventional cardiology clinical data and new device technologies were highlighted at the annual Transca ...

Home November 04, 2019
Home
News | Venous Therapies

October 31, 2019 – In a large series of iliac vein stent cases, a blinded comparison found intravascular ultrasound ...

Home October 31, 2019
Home
Videos | Antiplatelet and Anticoagulation Therapies

Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...

Home October 17, 2019
Home
News | Stents Drug Eluting

October 11, 2019 — The ultra-thin Supraflex drug-eluting stent (DES) from SMT maintained numerically lower outcomes at ...

Home October 11, 2019
Home
Videos | Antiplatelet and Anticoagulation Therapies

Ajay J. Kirtane, M.D., associate professor of medicine at Columbia University Irving Medical Center and director of the ...

Home October 11, 2019
Home
Videos | Antiplatelet and Anticoagulation Therapies

Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...

Home October 10, 2019
Home
TCT 2019 Late-breaking Presentations in the main arena. The top interventional cardiology studies of 2019. #TCT #TCT19 #TCT2019
Feature | TCT

October 10, 2019 — Here are the Cardiovascular Research Foundation (CRF) 12 late-breaking trials and 16 late-breaking ...

Home October 11, 2019
Home
Videos | Antiplatelet and Anticoagulation Therapies

American Heart Association President Robert Harrington, M.D., interventional cardiologist and the Arthur L. Bloomfield ...

Home October 08, 2019
Home
People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019
Feature | Cath Lab

October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...

Home October 03, 2019
Home
News | Cath Lab | Dave Fornell, Editor

October 2, 2019 — Democratic presidential candidate Sen. Bernie Sanders (D-VT) was hospitalized with chest pain on Oct ...

Home October 02, 2019
Home
Subscribe Now